Condition: Rectal Cancer Patients · Robotic Assisted Intervention · Sponsor: Sun Yat-sen University
TME remains standard treatment for rectal cancer. Both Robotic TME and taTME are innovative surgical techniques with potential advantages in low rectal cancer. To date, no clinical studies have directly compared the conversion and complication rates between taTME and RTME in this population. Therefore, the investigators propose to conduct a prospective, randomized, parallel-controlled clinical trial comparing taTME with RTME for low rectal cancer, aiming to provide high-level evidence for surgical decision-making and benefit more patients.
This description comes directly from the study's public registry record.
Liang Kang, MD · +8613602886833 · kangl@mail.sysu.edu.cn
Ling Shuang Luo, MD · +8613751756175 · kangl@mail.sysu.edu.cn
Always discuss trial participation with your own doctor first.
| the sixth affiliated hospital of Sun Yat-sen University | Guangzhou, Guangdong, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07651553